Chong Kun Dang Pharmaceutical Future Growth
Future criteria checks 0/6
Chong Kun Dang Pharmaceutical's earnings are forecast to decline at 18.6% per annum while its annual revenue is expected to grow at 2.1% per year. EPS is expected to decline by 21.1% per annum. Return on equity is forecast to be 11.6% in 3 years.
Key information
-18.6%
Earnings growth rate
-21.1%
EPS growth rate
| Pharmaceuticals earnings growth | 37.7% |
| Revenue growth rate | 2.1% |
| Future return on equity | 11.6% |
| Analyst coverage | Good |
| Last updated | 22 Aug 2024 |
Recent future growth updates
Recent updates
Does Chong Kun Dang Pharmaceutical (KRX:185750) Deserve A Spot On Your Watchlist?
Sep 08
Are Investors Undervaluing Chong Kun Dang Pharmaceutical Corp. (KRX:185750) By 41%?
Jul 30Investors Don't See Light At End Of Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Tunnel
Jun 12Chong Kun Dang Pharmaceutical (KRX:185750) Seems To Use Debt Rather Sparingly
May 27A Look At The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
Apr 09Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?
Apr 19Here's Why I Think Chong Kun Dang Pharmaceutical (KRX:185750) Is An Interesting Stock
Apr 05Declining Stock and Solid Fundamentals: Is The Market Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750)?
Mar 09Estimating The Fair Value Of Chong Kun Dang Pharmaceutical Corp. (KRX:185750)
Feb 24The Chong Kun Dang Pharmaceutical (KRX:185750) Share Price Is Up 112% And Shareholders Are Boasting About It
Feb 11Is Chong Kun Dang Pharmaceutical Corp. (KRX:185750) An Attractive Dividend Stock?
Jan 27
Does Chong Kun Dang Pharmaceutical (KRX:185750) Have A Healthy Balance Sheet?
Jan 12With EPS Growth And More, Chong Kun Dang Pharmaceutical (KRX:185750) Is Interesting
Dec 28What Kind Of Shareholders Hold The Majority In Chong Kun Dang Pharmaceutical Corp.'s (KRX:185750) Shares?
Dec 09Could The Market Be Wrong About Chong Kun Dang Pharmaceutical Corp. (KRX:185750) Given Its Attractive Financial Prospects?
Nov 24Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,730,750 | 121,829 | 158,833 | 169,263 | 8 |
| 12/31/2025 | 1,643,038 | 106,243 | 139,833 | 154,900 | 8 |
| 12/31/2024 | 1,564,300 | 95,571 | 103,000 | 137,500 | 5 |
| 6/30/2024 | 1,666,522 | 212,788 | 196,160 | 257,825 | N/A |
| 3/31/2024 | 1,665,726 | 202,243 | 249,344 | 321,128 | N/A |
| 12/31/2023 | 1,669,404 | 212,521 | 249,354 | 318,160 | N/A |
| 9/30/2023 | 1,561,851 | 136,097 | 134,793 | 206,913 | N/A |
| 6/30/2023 | 1,542,134 | 119,045 | 52,863 | 125,597 | N/A |
| 3/31/2023 | 1,512,154 | 99,381 | 51,004 | 103,844 | N/A |
| 12/31/2022 | 1,488,345 | 80,953 | 14,670 | 67,734 | N/A |
| 9/30/2022 | 1,453,159 | 70,692 | -31,835 | 12,119 | N/A |
| 6/30/2022 | 1,411,508 | 44,292 | -24,844 | 19,113 | N/A |
| 3/31/2022 | 1,373,018 | 45,096 | -35,295 | 13,964 | N/A |
| 12/31/2021 | 1,343,559 | 42,720 | -38,930 | 12,904 | N/A |
| 9/30/2021 | 1,318,914 | 52,319 | 15,268 | 66,304 | N/A |
| 6/30/2021 | 1,335,066 | 85,116 | 38,978 | 87,610 | N/A |
| 3/31/2021 | 1,321,558 | 88,792 | 49,408 | 92,670 | N/A |
| 12/31/2020 | 1,303,006 | 91,633 | 67,506 | 104,324 | N/A |
| 9/30/2020 | 1,263,965 | 96,316 | 61,955 | 95,132 | N/A |
| 6/30/2020 | 1,186,156 | 75,889 | 60,989 | 92,526 | N/A |
| 3/31/2020 | 1,138,689 | 60,916 | 48,310 | 76,123 | N/A |
| 12/31/2019 | 1,079,338 | 53,882 | 52,429 | 77,291 | N/A |
| 9/30/2019 | 1,046,387 | 51,327 | 66,180 | 89,129 | N/A |
| 6/30/2019 | 1,000,910 | 50,378 | 55,222 | 75,429 | N/A |
| 3/31/2019 | 971,688 | 50,422 | 27,158 | 50,953 | N/A |
| 12/31/2018 | 956,219 | 42,399 | 17,988 | 42,628 | N/A |
| 9/30/2018 | 934,982 | 43,682 | 4,847 | 33,677 | N/A |
| 6/30/2018 | 919,534 | 46,688 | 21,127 | 48,954 | N/A |
| 3/31/2018 | 893,204 | 45,204 | N/A | 65,370 | N/A |
| 12/31/2017 | 884,363 | 53,807 | N/A | 81,673 | N/A |
| 12/31/2016 | 831,986 | 40,946 | N/A | 57,786 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A185750's earnings are forecast to decline over the next 3 years (-18.6% per year).
Earnings vs Market: A185750's earnings are forecast to decline over the next 3 years (-18.6% per year).
High Growth Earnings: A185750's earnings are forecast to decline over the next 3 years.
Revenue vs Market: A185750's revenue (2.1% per year) is forecast to grow slower than the KR market (10.4% per year).
High Growth Revenue: A185750's revenue (2.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A185750's Return on Equity is forecast to be low in 3 years time (11.6%).